Stuttgart
30.12.25 | 08:42
0,002 Euro
+7,14 % +0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,002 | 0,016 | 20:05 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:20 | Episurf Medical AB receives observation status | 33 | GlobeNewswire | Today, December 30, 2025, Episurf Medical AB (the "Company") issued a press release with information that the Company had entered into an agreement regarding the acquisition of all shares in Goldcup... ► Artikel lesen | |
| 14:45 | Episurf Medical AB: Episurf forms a new strategic business segment through the acquisition of real estate assets. The purchase price of SEK up to 1,147 million is partly paid through shares, convertibles and warrants | 48 | GlobeNewswire (Europe) | The Board of Directors of Episurf Medical AB (publ) (NASDAQ: EPIS B) ("Episurf" or the "Company") has today, 30 December 2025, entered into an agreement with Goldcup 38657 AB (under name change to Frusipe... ► Artikel lesen | |
| 18.11. | Update on Episurf Medical's MTP implant | 3 | Cision News | ||
| 02.11. | Board Member Resigns from the Board of Episurf Medical | 2 | Cision News | ||
| 24.10. | Episurf Medical AB: Interim Report 1 January - 30 September 2025 | 134 | GlobeNewswire (Europe) | Strong US growth in gross-order intake and customer base
Significantly improved financial results
Continued focus on regulatory pathway for MTP-implant
"This is my first CEO statement as CEO... ► Artikel lesen | |
| EPISURF MEDICAL Aktie jetzt für 0€ handeln | |||||
| 17.10. | EPISURF MEDICAL AB: Scientific article on Episealer Knee with up to 10 years' follow-up published | 3 | Cision News | ||
| 12.10. | Board Member Resigns from the Board of Episurf Medical | 3 | Cision News | ||
| 30.09. | Change in number of shares and votes in Episurf Medical | 2 | Cision News | ||
| 16.09. | Episurf Medical AB: New Chief Executive Officer at Episurf Medical | 333 | GlobeNewswire (Europe) | Episurf Medical (Nasdaq: EPIS B) today announces that, at his own request, Pål Ryfors will step down as Chief Executive Officer of Episurf Medical. The Board of Directors has appointed Katarina Flodström... ► Artikel lesen | |
| 01.09. | EPISURF MEDICAL AB: Episealer included in the Swedish Knee Arthroplasty Register 2025 | 4 | Cision News | ||
| 29.08. | Episurf Medical AB changes liquidity provider to Mangold Fondkommission AB | 2 | Cision News | ||
| 28.08. | Episurf Medical resolves on an issue of units to guarantors in connection with the completed rights issue | 1 | Cision News | ||
| 25.08. | Episurf Medical announces final outcome of the rights issue | 1 | Cision News | ||
| 22.08. | EPISURF MEDICAL AB: Preliminary outcome indicates significantly oversubscribed rights issue | 1 | Cision News | ||
| 20.08. | Episurf Medical announces interview with CEO | 1 | Cision News | ||
| 07.08. | Listing of units rights and paid subscription units of Episurf Medical AB | 327 | GlobeNewswire | With effect from August 08, 2025, the units rights of Episurf Medical AB will be traded on the list for Equity rights. Trading will continue up until and including August 19, 2025.
Instrument:
Units... ► Artikel lesen | |
| 05.08. | Episurf Medical publishes prospectus in connection with the company's rights issue of units | 2 | Cision News | ||
| 04.08. | Episurf Medical AB: Summary from the Extraordinary General Meeting of Episurf Medical AB (publ) | 235 | GlobeNewswire (Europe) | Episurf Medical AB (publ) held an Extraordinary General Meeting in Stockholm today 4 August 2025 at which it was resolved, among other things, to approve the Board of Directors' resolution on a rights... ► Artikel lesen | |
| 04.08. | XFRA CAPITAL ADJUSTMENT INFORMATION - 04.08.2025 | 636 | Xetra Newsboard | Das Instrument 5QO SE0016829824 QLUCORE AB EQUITY wird cum Kapitalmassnahme gehandelt am 04.08.2025 und ex Kapitalmassnahme am 05.08.2025 The instrument 5QO SE0016829824 QLUCORE AB EQUITY is traded... ► Artikel lesen | |
| 01.08. | The Swedish Securities Council grants exemption from the obligation to submit a mandatory offer in connection with Episurf Medical's rights issue of units | 2 | Cision News |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IMUNON | 3,140 | +0,64 % | IMUNON raises $7 million in registered direct offering | ||
| ELECTROCORE | 3,820 | 0,00 % | electroCore, Inc.: electroCore Announces Third Quarter 2025 Financial Results | Net sales of $8.7 million increased 33% vs. Q3 2024; YTD net sales of $22.8 million increased 26% vs. first nine months of 2024 Cash, cash equivalents, restricted cash, and marketable securities ("Total... ► Artikel lesen | |
| EKSO BIONICS | 10,640 | +94,87 % | Applied Digital Corporation: Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale | DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,920 | +0,54 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,760 | +0,37 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 48,980 | +0,60 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,000 | -1,57 % | EILMELDUNG: Carl Zeiss Meditec-Aktie tritt auf der Stelle - Anleger warten auf das nächste Signal. | ||
| GENEDX | 127,75 | -1,23 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,150 | +1,11 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 37,750 | -0,24 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GERRESHEIMER | 27,580 | 0,00 % | Thyssen hui, Gerresheimer ... - die besten und schlechtesten deutschen Aktien 2025 | Die Börse in Frankfurt hat um 14 Uhr den Handel für das Jahr 2025 beendet. Damit stehen nun auch die Gewinner und Verlierer des Jahres im HDAX fest. Hier sind sie. Die Gewinner 2025 Mit einem Plus von... ► Artikel lesen | |
| PROGYNY | 25,800 | +0,70 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PROFUSA | 0,126 | +83,19 % | Profusa ermöglicht Verkauf von Schuldverschreibungen im Wert von 5 Mio. US-Dollar durch Vertragsanpassung | ||
| PACS GROUP | 39,950 | +2,36 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 31,860 | -0,82 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |
Das Unternehmen EPISURF MEDICAL AB kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,000 (+7,14 %) liegt der Kurs bei 0,002 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EPISURF MEDICAL AB finden Sie auf Wallstreet Online.